Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 153,282 | 108,887 | 44,390 | 43,799 | 18,597 |
| Cost of Goods | 46,930 | 34,581 | 0 | 0 | 0 |
| Gross Profit | 106,352 | 74,306 | 44,390 | 43,799 | 18,597 |
| Operating Expenses | 144,725 | 126,528 | 76,790 | 63,054 | 43,141 |
| Operating Income | -37,443 | -51,641 | -32,400 | -19,255 | -24,544 |
| Interest Expense | 11,653 | 1,704 | 680 | 576 | 462 |
| Other Income | 17,517 | 12,191 | 0 | 0 | -14,999 |
| Pre-tax Income | -31,579 | -41,154 | -33,080 | -19,831 | -40,005 |
| Net Income Continuous | -31,579 | -41,154 | -33,086 | -19,831 | -24,967 |
| Net Income | $-34,740 | $-41,154 | $-33,080 | $-19,831 | $-40,005 |
| EPS Basic Total Ops | -0.51 | -0.66 | -0.66 | -0.41 | -1.07 |
| EPS Basic Continuous Ops | -0.47 | -0.66 | -0.65 | -0.41 | -0.66 |
| EPS Diluted Total Ops | -0.51 | -0.66 | -0.66 | -0.41 | -1.07 |
| EPS Diluted Continuous Ops | -0.47 | -0.66 | -0.65 | -0.41 | -0.66 |
| EBITDA(a) | $-24,651 | $-41,970 | $-27,880 | $-15,667 | $-21,384 |